CSS
FSTX

Cubist Systematic Strategies’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Cubist Systematic Strategies’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-66
Closed – – 4704
2022
Q1 		$0 Sell
66
-5,796
-99% -$21.4K ﹤0.01% 3935
2021
Q4 		$29K Buy
+5,862
New +$35.4K ﹤0.01% 3360
2021
Q3 		– Sell
-1,169
Closed -$10K – 3268
2021
Q2 		$10K Buy
+1,169
New +$9.97K ﹤0.01% 2865

Other funds holding FSTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's FSTX Position: Q2 2022 in Review

Cubist Systematic Strategies sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2022, closing a stake of 66 shares.

Cubist Systematic Strategies first reported a position in FSTX in Q2 2021 and held it in 3 quarters. The position peaked at $29K in Q4 2021. 53 funds tracked by Wall St. Rank hold FSTX as of Q2 2022.

  • Cubist Systematic Strategies reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 66 F-star Therapeutics, Inc. Common Stock shares in Q2 2022.
  • Cubist Systematic Strategies first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Cubist Systematic Strategies's F-star Therapeutics, Inc. Common Stock position peaked at $29K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.